Yes, let's dig up a 4 month old article with quotes from the failed deal partner Basic Dental and references to the failed deal partner Carpenter Tech. Let's not discuss the $2 million loss in the latest 10-Q or that, at this rate, in less than a year from now the entire $8 million cash settlement from CRS will be gone. Let's not discuss the new shares that continue to be doled out to consultants and insiders. Let's not even speculate on when any of this might change.
From latest 10-Q:
NOTE 4 - CAPITAL TRANSACTIONS
Capital transactions during the six months ended June 30, 2015:
In January 2015, the Company issued 1,000,000 shares of common stock to a party for services with a total value $90,000.
In January 2015, the Company entered into an employment agreement whereby the employee would earn 10,000,000 shares of common stock over a twenty four month period. As of June 30, 2015, the employee had earned and accrued 2,083,000 shares with a value of $188.000. As of June 30, 2015, these shares have not been issued and recorded as a stock payable within the current liabilities of the balance sheet.
In March 2015, the Company issued 1,000,000 shares of common stock and warrant for 2,500,000 shares of common stock one of the Company's directors for legal services rendered with a total value of $160,000.
In May 2015, the Company awarded 250,000 shares of common stock to a consultant for services rendered with a total value of $18,000. As June 30, 2015, these shares had not been issued and recorded as a stock payable and reflected as a contra-equity within the stockholders' equity of the balance sheet. These shares have been subsequently issued in July 2015, see Note 9.
In May 2015, the Company issued 625,000 shares of common stock for satisfaction of an accrued liability for legal services previously rendered in 2014 with a total value of $69,000.
In June 2015, the Company awarded 3,000,000 shares of common stock to a consultant for services rendered with a total value of $180,000. As of June 30, 2015, these shares had not been issued and recorded as a stock payable and reflected as a contra-equity within the stockholders' equity of the balance sheet. These shares have been subsequently issued in July 2015, see Note 9.
In June 2015, the Company awarded all members of the Company's board of director's stock options for 500,000 shares each for a total of 3,000,000 shares, with an exercise price of $0.05 per share with a 10 year life. The stock options awarded totaled $137,000 which the Company used the Black-Scholes option pricing model to calculate the compensation expense for the option grants using the following inputs: exercise price of $0.05 per share, risk free rate of 2.0%, volatility of 149% and zero dividends.
News 
Market Data 
Discover 
